|
RELA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.659860E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.161200E-03 |
| Normal-vs-Stage2 |
3.689800E-02 |
| Normal-vs-Stage3 |
4.376600E-01 |
| Normal-vs-Stage4 |
3.090600E-01 |
| Stage1-vs-Stage2 |
8.688000E-01 |
| Stage1-vs-Stage3 |
1.011610E-01 |
| Stage1-vs-Stage4 |
4.959000E-01 |
| Stage2-vs-Stage3 |
3.242600E-01 |
| Stage2-vs-Stage4 |
6.321800E-01 |
| Stage3-vs-Stage4 |
7.591800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.798300E-03 |
| Normal-vs-AfricanAmerican |
1.352230E-01 |
| Normal-vs-Asian |
1.086200E-01 |
| Caucasian-vs-AfricanAmerican |
1.557030E-01 |
| Caucasian-vs-Asian |
7.546000E-01 |
| AfricanAmerican-vs-Asian |
4.360400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.661100E-03 |
| Normal-vs-Female |
3.323800E-01 |
| Male-vs-Female |
1.581980E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.955500E-02 |
| Normal-vs-Extreme_Weight |
5.317700E-03 |
| Normal-vs-Obese |
2.399800E-01 |
| Normal-vs-Extreme_Obese |
3.964600E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.131600E-01 |
| Normal_Weight-vs-Obese |
2.133400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.458100E-02 |
| Extreme_Weight-vs-Obese |
8.153900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.104400E-02 |
| Obese-vs-Extreme_Obese |
1.560220E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.030200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.188100E-02 |
| Normal-vs-Age(61-80Yrs) |
8.967400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.026110E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.342400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.234400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.576200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.973720E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.108580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.892200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.922410E-02 |
| Normal-VS-Type2 PRCC |
3.82780000000027E-05 |
| Normal-VS-KIRP CIMP |
6.558300E-03 |
| Normal-VS-Unclassified PRCC |
1.438200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.443680E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.98190999999293E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.830800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.46739999543166E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
2.034300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.788700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.59380000000531E-05 |
| Normal-vs-N1 |
9.036200E-01 |
| Normal-vs-N2 |
5.081800E-01 |
| N0-vs-N1 |
1.073740E-02 |
| N0-vs-N2 |
2.891800E-01 |
| N1-vs-N2 |
6.198400E-01 |
|
|
